US FDA approves Adaptimmune therapy for a rare type of cancer
The US Food and Drug Administration (FDA) announced that it has approved Adaptimmune, a pioneering treatment for a rare type of soft tissue cancer that usually affects young adults.
BELIEBTE BEITRÄGE
Poland prepares for peaking floods
September 20, 2024
Italy evacuates thousands as Boris hits the north
September 20, 2024
China and the US race to tame nuclear fusion for clean energy
September 20, 2024
LIVEÜBERTRAGUNG